Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.
Kim SA, Park H, Kim KJ, Kim JW, Sung JH, Nam M, Lee JH, Jung EH, Suh KJ, Lee JY, Kim SH, Lee JO, Kim JW, Kim YJ, Kim JH, Bang SM, Lee JS, Lee KW.
Kim SA, et al. Among authors: kim kj, kim yj, kim sh, kim jw, kim jh.
J Cancer Res Clin Oncol. 2022 Nov;148(11):2995-3005. doi: 10.1007/s00432-021-03872-4. Epub 2021 Dec 1.
J Cancer Res Clin Oncol. 2022.
PMID: 34853888